Item | Score | |
---|---|---|
1 | Is the hypothesis/aim/objective of the study clearly described? | yes=1; no=0 |
2 | Are the main outcomes to be measured clearly described in the Introduction or Methods section? | yes=1; no=0 |
3 | Are the characteristics of the patients included in the study clearly described? | yes=1; no=0 |
4 | * Are the interventions of interest clearly described? | yes=1; no=0 |
5 | Are the distributions of principal confounders in each group of subjects to be compared clearly described? | yes=2; partially=1; no=0 |
6 | Are the main findings of the study clearly described? | yes=1; no=0 |
7 | Does the study provide estimates of the random variability in the data for the main outcomes? | yes=1; no=0 |
8 | * Have all important adverse events that may be a consequence of the intervention been reported? | yes=1; no=0 |
9 | Have the characteristics of patients lost to follow-up been described? | yes=1; no=0 |
10 | Have actual probability values been reported (e.g. 0.035 rather than <0.05) for the main outcomes except where the probability value is less than 0.001? | yes=1; no=0 |
11 | Were the subjects asked to participate in the study representative of the entire population from which they were recruited? | yes=1; no=0 |
12 | Were those subjects who were prepared to participate representative of the entire population from which they were recruited? | yes=1; no=0 |
13 | Were the staff, places, and facilities where the patients were treated, representative of the treatment the majority of patients receive? | yes=1; no=0 |
14 | * Was an attempt made to blind study subjects to the intervention they have received? | yes=1; no=0 |
15 | Was an attempt made to blind those measuring the main outcomes of the intervention? | yes=1; no=0 |
16 | If any of the results of the study were based on “data dredging”, was this made clear? | yes=1; no=0 |
17 | In trials and cohort studies, do the analyses adjust for different lengths of follow-up of patients, or in case-control studies, is the time period between the intervention and outcome the same for cases and controls? | yes=1; no=0 |
18 | Were the statistical tests used to assess the main outcomes appropriate? | yes=1; no=0 |
19 | * Was compliance with the intervention/s reliable? | yes=1; no=0 |
20 | Were the main outcome measures used accurate (valid and reliable)? | yes=1; no=0 |
21 | Were the patients in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited from the same population? | yes=1; no=0 |
22 | Were study subjects in different intervention groups (trials and cohort studies) or were the cases and controls (case-control studies) recruited over the same period of time? | yes=1; no=0 |
23 | * Were study subjects randomized to intervention groups? | yes=1; no=0 |
24 | * Was the randomized intervention assignment concealed from both patients and health care staff until recruitment was complete and irrevocable? | yes=1; no=0 |
25 | Was there adequate adjustment for confounding in the analyses from which the main findings were drawn? | yes=1; no=0 |
26 | Were losses of patients to follow-up taken into account? | yes=1; no=0 |
27 | * Did the study have sufficient power to detect a clinically important effect where the probability value for a difference being due to chance is less than 5%? | Size of smallest intervention group: <n1=0; n1-n2=1; n3-n4=2; n5-n6=3; n7-n8=4; n8+=5 |
Items 1–10 = reporting, 11–13 = external validity, 14–20 = internal validity (bias), 21–26 = internal validity (confounding) and 27 = power.
not applicable to observational studies.